newsfilter
← Latest News
PR Newswire·

BiondVax to host analyst and investor webinar on April 4th

JERUSALEM, March 31, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and ot